Global Wealth Management Investment Advisory, Inc. Novavax Inc Transaction History

Global Wealth Management Investment Advisory, Inc.

$429 Million
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$6.67 - $9.52 $600 - $856	90 New	90 $0
Q1 2022 May 17, 2022	BUY	$69.73 - $142.9 $6,275 - $12,861	90 New	90 $7,000
Q3 2021 Nov 16, 2021	SELL	$177.8 - $270.58 $1,778 - $2,705	-10 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$121.0 - $257.67 $1,210 - $2,576	10 New	10 $2,000
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $9,490 - $26,874	-84 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $787 - $1,395	10 Added 13.51%	84 $9,000
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $2,065 - $4,641	-26 Reduced 26.0%	74 $8,000
Q2 2020 Aug 12, 2020	BUY	$13.86 - $83.61 $1,386 - $8,361	100 New	100 $8,000

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.01B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.

Account